Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Megna

Showing results (51-60 of 381) with videos related to

Pageof 39
Sort By:
Dermatologic Therapy|June 17, 2021
Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?Matteo Megna, Luca Potestio, Gabriella Fabbrocini, et al.
Case Reports in Dermatology|October 1, 2020
A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical TacrolimusClaudio Marasca, Angelo Ruggiero, Gabriella Fabbrocini, et al.
Dermatologic Therapy|December 14, 2020
Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti-interleukin-17 treatment: A real-life 52-week retrospective studyAngelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli, et al.
Dermatologic Therapy|November 20, 2021
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective studyAngelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli, et al.
Clinical and Experimental Dermatology|December 10, 2024
Climate change and the role of dermatologists: a call to actionLuca Potestio, Fabrizio Martora, Alessia Villani, et al.
Archives of Dermatological Research|December 12, 2024
Long-term efficacy and safety of bimekizumab in real-world setting: a 52-week prospective studyLuca Potestio, Angelo Ruggiero, Fabrizio Martora, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 16, 2018
Pityriasis versicolor with uncommon localizationsVincenzo Greco, Matteo Megna, Maria A Luciano, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2025
Successful treatment of durvalumab-induced psoriasis in an HBV-positive lung cancer patient with Risankizumab: A novel case reportDavide Fattore, Francesca Futura Bernardi, Gianluca Esposito, et al.
Indian Journal of Dermatology, Venereology and Leprology|March 17, 2012
Patient-physician relationship in patients with psoriasisCataldo Patruno, Fabio Ayala, Matteo Megna, et al.
Expert Opinion on Drug Safety|December 17, 2022
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledgeAngelo Ruggiero, Elisa Camela, Luca Potestio, et al.
Pageof 39

Showing results (51-60 of 381) with videos related to

Sort By:
Pageof 39
Dermatologic Therapy|June 17, 2021
Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?Matteo Megna, Luca Potestio, Gabriella Fabbrocini, et al.
Case Reports in Dermatology|October 1, 2020
A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical TacrolimusClaudio Marasca, Angelo Ruggiero, Gabriella Fabbrocini, et al.
Dermatologic Therapy|December 14, 2020
Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti-interleukin-17 treatment: A real-life 52-week retrospective studyAngelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli, et al.
Dermatologic Therapy|November 20, 2021
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective studyAngelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli, et al.
Clinical and Experimental Dermatology|December 10, 2024
Climate change and the role of dermatologists: a call to actionLuca Potestio, Fabrizio Martora, Alessia Villani, et al.
Archives of Dermatological Research|December 12, 2024
Long-term efficacy and safety of bimekizumab in real-world setting: a 52-week prospective studyLuca Potestio, Angelo Ruggiero, Fabrizio Martora, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 16, 2018
Pityriasis versicolor with uncommon localizationsVincenzo Greco, Matteo Megna, Maria A Luciano, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2025
Successful treatment of durvalumab-induced psoriasis in an HBV-positive lung cancer patient with Risankizumab: A novel case reportDavide Fattore, Francesca Futura Bernardi, Gianluca Esposito, et al.
Indian Journal of Dermatology, Venereology and Leprology|March 17, 2012
Patient-physician relationship in patients with psoriasisCataldo Patruno, Fabio Ayala, Matteo Megna, et al.
Expert Opinion on Drug Safety|December 17, 2022
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledgeAngelo Ruggiero, Elisa Camela, Luca Potestio, et al.
Pageof 39